Dr. Omar Nadeem, MD
Claim this profileDana Farber Cancer Institute
Expert in Multiple Myeloma
Expert in Plasma Cell Neoplasms
18 reported clinical trials
26 drugs studied
About Omar Nadeem, MD
Education:
- MD from Harvard Medical School, 2015.
- Residency in Internal Medicine at Massachusetts General Hospital, 2018.
- Fellowship in Hematology and Oncology at Dana-Farber Cancer Institute/Brigham and Women's Hospital, 2021.
Experience:
- Specializes in hematology and oncology.
- Affiliated with Dana-Farber Cancer Institute and Brigham and Women's Hospital.
Affiliated Hospitals
Clinical Trials Omar Nadeem, MD is currently running
Iberdomide + Daratumumab vs. Bortezomib
for Multiple Myeloma
This is a multicenter, two-stage, randomized, controlled, open-label, Phase 3 study comparing the efficacy and safety of iberdomide in combination with dexamethasone and daratumumab (IberDd) versus daratumumab, bortezomib, and dexamethasone (DVd) in participants with relapsed or refractory multiple myeloma (RRMM).
Recruiting2 awards Phase 3
Ixazomib + Pomalidomide + Dexamethasone
for Multiple Myeloma
This is a Phase I/II study using the combination of twice weekly ixazomib plus pomalidomide and dexamethasone in relapsed and or refractory multiple myeloma (RRMM) patients.
Recruiting1 award Phase 1 & 210 criteria
More about Omar Nadeem, MD
Clinical Trial Related4 years of experience running clinical trials · Led 18 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Omar Nadeem, MD has experience with
- Dexamethasone
- Daratumumab
- Lenalidomide
- Pomalidomide
- Bortezomib
- Ixazomib
Breakdown of trials Omar Nadeem, MD has run
Multiple Myeloma
Plasma Cell Neoplasms
Recurrence
Paraproteinemia
Monoclonal Gammopathy
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Omar Nadeem, MD specialize in?
Omar Nadeem, MD focuses on Multiple Myeloma and Plasma Cell Neoplasms. In particular, much of their work with Multiple Myeloma has involved Stage IV patients, or patients who are undergoing treatment.
Is Omar Nadeem, MD currently recruiting for clinical trials?
Yes, Omar Nadeem, MD is currently recruiting for 5 clinical trials in Boston Massachusetts. If you're interested in participating, you should apply.
Are there any treatments that Omar Nadeem, MD has studied deeply?
Yes, Omar Nadeem, MD has studied treatments such as Dexamethasone, Daratumumab, Lenalidomide.
What is the best way to schedule an appointment with Omar Nadeem, MD?
Apply for one of the trials that Omar Nadeem, MD is conducting.
What is the office address of Omar Nadeem, MD?
The office of Omar Nadeem, MD is located at: Dana Farber Cancer Institute, Boston, Massachusetts 02215 United States. This is the address for their practice at the Dana Farber Cancer Institute.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.